Common use of Amendments and Supplements to the Prospectus and Other Securities Act Matters Clause in Contracts

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunder, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e).

Appears in 14 contracts

Samples: Underwriting Agreement (FS Development Corp. II), Underwriting Agreement (CM Life Sciences, Inc.), Underwriting Agreement (Ark Global Acquisition Corp.)

AutoNDA by SimpleDocs

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e).

Appears in 13 contracts

Samples: Underwriting Agreement (Glass Houses Acquisition Corp.), Underwriting Agreement (Clarim Acquisition Corp.), Underwriting Agreement (HealthCor Catalio Acquisition Corp.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating prior to the Offered Securities is required to be delivered under later of (x) the Securities ActClosing Date and (y) the end of the Prospectus Delivery Period (as defined below), any event shall occur or condition exist as a result of which it is necessary (i) the Time of Sale Information (prior to amend the Closing Date) or supplement the Prospectus so that (prior to the later of the Closing Date and the end of the Prospectus does not Delivery Period), in both cases as then amended or supplemented, would include an any untrue statement of a material fact or omit to state a any material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchasercircumstances, not misleading, misleading or if (ii) it shall be is necessary to amend the Registration Statement or supplement the Time of Sale Information (prior to the Closing Date) or the Prospectus (prior to the later of the Closing Date and the end of the Prospectus Delivery Period) to comply with the Securities Act or rules thereunderlaw, the Company agrees (will promptly notify the Underwriters thereof and forthwith prepare and, subject to Section 3(bparagraph (a) and Section 3(c) hereof) to promptly prepareabove, file with the Commission (to the extent required) and furnish, at its own expense, furnish to the Underwriters and to any dealer upon requestsuch dealers as the Representatives may designate, such amendments or supplements to the Time of Sale Information (prior to the Closing Date) or the Prospectus (prior to the later of the Closing Date and the end of the Prospectus Delivery Period) as may be necessary so that the statements in the Time of Sale Information (prior to the Closing Date) or the Prospectus (prior to the later of the Closing Date and the end of the Prospectus Delivery Period), in both cases as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements thereinnot, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchasercircumstances, not be misleading or so that the Prospectus, as amended Time of Sale Information (prior to the Closing Date) or supplemented, the Prospectus (prior to the later of the Closing Date and the end of the Prospectus Delivery Period) will comply with law. The Company hereby expressly acknowledges that the Securities Act or the rules thereunder. Neither the Representative’s consent toindemnification and contribution provisions of Sections 8 and 9 hereof are specifically applicable and relate to each registration statement, nor delivery ofprospectus, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under referred to in this Section 3(b) or Section 3(e)3.

Appears in 11 contracts

Samples: Underwriting Agreement (Republic Services, Inc.), Underwriting Agreement (Republic Services, Inc.), Underwriting Agreement (Republic Services, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunder, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e).

Appears in 10 contracts

Samples: Underwriting Agreement (Authentic Equity Acquisition Corp.), Underwriting Agreement (ARYA Sciences Acquisition Corp IV), Underwriting Agreement (ARYA Sciences Acquisition Corp III)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 6 contracts

Samples: Underwriting Agreement (Sterling Bancorp), Underwriting Agreement (Sterling Bancorp), Underwriting Agreement (Sterling Bancorp)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Sections 4(d) and 4(f); provided, however that the only remedy the Agent shall have with respect to the failure by the Company to make such filing (other than the Agent’s rights under Section 3(b3(d) or Section 3(e)6 hereof) shall be to cease making sales under this Agreement until such amendment or supplement is filed; provided further, that the failure of the Company to file such amendment or supplement request shall not relieve the Company of any obligation or liability under Section 3(d) or Section 6 hereof, or affect the Agent’s right to rely on the representations and warranties made by the Company in this Agreement. Notwithstanding the foregoing, the Company shall not be required to file such amendment or supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement.

Appears in 5 contracts

Samples: Open Market Sale (Corvus Pharmaceuticals, Inc.), Corvus Pharmaceuticals, Inc., IDEAYA Biosciences, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(bSections 4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Sections 4(d) and 4(f); provided, however that the only remedy the Agent shall have with respect to the failure by the Company to make such filing (other than the Agent’s rights under Section 3(b3(d) or Section 3(e)6 hereof) shall be to cease making sales under this Agreement until such amendment or supplement is filed; provided further, that the failure of the Company to file such amendment or supplement request shall not relieve the Company of any obligation or liability under Section 3(d) or Section 6 hereof, or affect the Agent’s right to rely on the representations and warranties made by the Company in this Agreement. Notwithstanding the foregoing, the Company shall not be required to file such amendment or supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement.

Appears in 5 contracts

Samples: Open Market Sale (Ardelyx, Inc.), IDEAYA Biosciences, Inc., Ardelyx, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating Prior to the later of (i) the expiration or termination of the option granted to the several Underwriters in Section 2 and (ii) the completion of the Underwriters’ distribution of the Offered Securities is required to be delivered under the Securities ActShares, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b3(A)(b) and Section 3(c3(A)(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b3(A)(b) or Section 3(e3(A)(c).

Appears in 5 contracts

Samples: Underwriting Agreement (Edward S. Glazer Irrevocable Exempt Trust), Underwriting Agreement (Manchester United PLC), Underwriting Agreement (Manchester United PLC)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderAct. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e).

Appears in 5 contracts

Samples: Underwriting Agreement (Hunt Companies Acquisition Corp. I), Underwriting Agreement (Hunt Companies Acquisition Corp. I), Underwriting Agreement (Perception Capital Corp. II)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agents or counsel for the Agents it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgents, amendments or supplements to the Prospectus (including by filing a document incorporated by reference therein) so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the Representative’s Agents’ consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(d) and Section 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no outstanding Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; provided, however, the Company agrees not to provide an Issuance Notice or otherwise sell under this Agreement until such amendment or supplement is filed.

Appears in 4 contracts

Samples: Sales Agreement (MICROSTRATEGY Inc), Sales Agreement (MICROSTRATEGY Inc), Sales Agreement (MICROSTRATEGY Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 4 contracts

Samples: Underwriting Agreement (Ocular Therapeutix, Inc), Underwriting Agreement (Ocular Therapeutix, Inc), Underwriting Agreement (Ocular Therapeutix, Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 4 contracts

Samples: Underwriting Agreement (Vector Group LTD), Underwriting Agreement (Vector Group LTD), Underwriting Agreement (Vector Group LTD)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c). As used herein, the term “Prospectus Delivery Period” means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Shares by any Underwriter or dealer.

Appears in 4 contracts

Samples: Underwriting Agreement (Xeris Pharmaceuticals Inc), Underwriting Agreement (Tcr2 Therapeutics Inc.), Underwriting Agreement (Xeris Pharmaceuticals Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspective Delivery Period (as defined below), any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Company, counsel for the Company, the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c). As used herein, the term “Prospectus Delivery Period” means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for Underwriters a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with the sales of Shares by any Underwriter or dealer.

Appears in 3 contracts

Samples: Underwriting Agreement (Scholar Rock Holding Corp), Underwriting Agreement (Scholar Rock Holding Corp), Underwriting Agreement (Codiak BioSciences, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event or development shall occur or condition exist as a result of which the Disclosure Package or the Prospectus as then supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein in the light of the circumstances under which they were made not misleading, or if it is shall be necessary to amend or supplement the Disclosure Package or the Prospectus in order to make the statements therein, in the light of the circumstances when the Disclosure Package or the Prospectus is delivered to a purchaser, not misleading, or if in the opinion of the Representative or counsel for the Underwriters it is otherwise necessary to amend or supplement the Disclosure Package or the Prospectus in order to comply with law, the Company agrees to (i) notify the Representative of any such event or condition and (ii) promptly prepare (subject to Sections 3(A)(b) and 3(A)(d) hereof), file with the Commission and furnish at its own expense to the Underwriters and to dealers, amendments or supplements to the Disclosure Package or the Prospectus, necessary in order to make the statements in the Disclosure Package or the Prospectus as so amended or supplemented, in the light of the circumstances when the Disclosure Package or the Prospectus is delivered to a purchaser, not misleading or so that the Disclosure Package or the Prospectus, as amended or supplemented, will comply with law. If at any time following the issuance of an Issuer Free Writing Prospectus does not there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement or any other registration statement relating to the Shares or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when under which they were made or prevailing at the Prospectus is delivered (whether physically time such event or through compliance with Rule 172 under the Securities Act development occurs or any similar rule) to a purchasercondition exists, not misleading, or if it shall be necessary to the Company will promptly notify the Representative and will promptly amend the Registration Statement or supplement the such Issuer Free Writing Prospectus to comply with the Securities Act eliminate or rules thereundercorrect such conflict, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e)omission.

Appears in 3 contracts

Samples: Underwriting Agreement (DG FastChannel, Inc), Global Traffic Network, Inc., Global Traffic Network, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the reasonable opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c). As used herein, the term “Prospectus Delivery Period” means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Shares by any Underwriter or dealer.

Appears in 3 contracts

Samples: Underwriting Agreement (Candel Therapeutics, Inc.), Underwriting Agreement (Forma Therapeutics Holdings, Inc.,), Underwriting Agreement (Ikena Oncology, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time during the period when a prospectus relating to the Offered Securities Shares is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities ActAct or any similar rule), any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable Law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable Law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 3 contracts

Samples: Underwriting Agreement (Evolus, Inc.), Underwriting Agreement (Evolus, Inc.), Underwriting Agreement (Evolus, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event shall occur or condition exist as a result of which it is necessary to amend the Registration Statement or amend or supplement the Prospectus in order to make the statements in the Prospectus, in light of the circumstances when the Prospectus is delivered to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters, it is otherwise necessary to amend the Registration Statement or supplement the Prospectus or to file a new registration statement to comply with the Securities Act, the Company agrees to promptly prepare (subject to Section 3(b)), file with the Commission, use its best efforts to have declared effective, if required, and furnish at its own expense to the Underwriters and to dealers, such amendments, supplements to the Prospectus or new registration statements so that the statements in the Prospectus does not as so amended or supplemented will not, in light of the circumstances when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus, as amended or supplemented, and the Registration Statement as amended, will comply with the Securities Act. If at any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement (or any other registration statement relating to the Notes) or the Prospectus or any Preliminary Prospectus or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaserprevailing at that subsequent time, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunder, the Company agrees (subject to Section 3(b) will promptly notify the Representatives and Section 3(c) hereof) to will promptly prepare, file with the Commission and furnishamend or supplement, at its own expense, such Issuer Free Writing Prospectus to the Underwriters and to any dealer upon requesteliminate or correct such conflict, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e)omission.

Appears in 3 contracts

Samples: Underwriting Agreement (JMP Group LLC), Underwriting Agreement (JMP Group LLC), Underwriting Agreement (JMP Group LLC)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Underwriter or counsel for the Underwriter it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b4(b) and Section 3(c4(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters Underwriter and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the RepresentativeUnderwriter’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(b) or Section 3(e4(c).

Appears in 3 contracts

Samples: Underwriting Agreement (Northwest Bancshares, Inc.), Underwriting Agreement (Park National Corp /Oh/), Underwriting Agreement (First Citizens Bancshares Inc /De/)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at If any time event shall occur or condition exist during the period when a prospectus relating to the Offered Securities Shares is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act, Act or any event shall occur or condition exist similar rule) as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b3(c) and Section 3(c3(d) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b3(c) or Section 3(e3(d).

Appears in 3 contracts

Samples: Underwriting Agreement (Heron Therapeutics, Inc. /De/), Underwriting Agreement (Heron Therapeutics, Inc. /De/), Underwriting Agreement (Heron Therapeutics, Inc. /De/)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Company, counsel for the Company, the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c) hereof)) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 2 contracts

Samples: Underwriting Agreement (Morphic Holding, Inc.), Underwriting Agreement (Morphic Holding, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, If at any time when the delivery of a prospectus relating to the Offered Securities is required to be delivered under the Securities ActAct or under the blue sky or securities laws of any jurisdiction on or prior to the applicable Settlement Date for any Selling Period in connection with the offering or sale of the Shares, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b) and Section 3(c) hereof4(d)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(b) or Section 3(e4(c).

Appears in 2 contracts

Samples: Olympic Steel Inc, Olympic Steel Inc

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary in the opinion of counsel for the Company or for the Underwriters to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b3 (b) and Section 3(c3 (c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3 (c).

Appears in 2 contracts

Samples: Underwriting Agreement (Icahn Enterprises L.P.), Underwriting Agreement (Icahn Enterprises L.P.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event shall occur or condition exist as a result of which it is necessary to amend the Registration Statement or amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements thereinin the Prospectus, in the light of the circumstances when prevailing at the time the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or, if in the opinion of the Representative or if counsel for the Underwriters, it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus or to file a new registration statement to comply with the Securities Act or rules thereunderAct, the Company agrees to promptly prepare (subject to Section 3(b3.1(a) (the "Representative's Review of Proposed Amendments and Section 3(cSupplements") hereof) to promptly prepare), file with the Commission Commission, use its best efforts to have declared effective, if required, and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestdealers, such amendments or and supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not not, in light of the circumstances prevailing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus, as amended or supplemented, and the Registration Statement, as amended, will comply with law. If at any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement (or any other registration statement relating to the Offered Shares), the Prospectus or any Preliminary Prospectus, included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaserprevailing at that subsequent time, not misleading misleading, the Company will promptly notify the Representative and will promptly amend or so that the Prospectussupplement, as amended at its own expense, such Issuer Free Writing Prospectus to eliminate or supplementedcorrect such conflict, will comply with the Securities Act untrue statement or the rules thereunder. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e)omission.

Appears in 2 contracts

Samples: Underwriting Agreement (Red Lion Hotels CORP), Underwriting Agreement (Red Lion Hotels CORP)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event or development shall occur or condition exist as a result of which it is necessary to amend the Disclosure Package or supplement the Prospectus so that the Prospectus does not as then supplemented would include an any untrue statement of a material fact or omit to state a any material fact necessary in order to make the statements therein in the light of the circumstances under which they were made not misleading, or if it shall be necessary to amend or supplement the Disclosure Package or the Prospectus in order to make the statements therein, in the light of the circumstances when the Disclosure Package or the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Disclosure Package or the Prospectus in order to comply with the Securities Act or rules thereunderlaw, the Company agrees to (i) notify the Representatives of any such event or condition and (ii) promptly prepare (subject to Section 3(bSections 3(a) and Section 3(c3(e) hereof) to promptly prepare), file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestdealers, amendments or supplements to the Prospectus so that Disclosure Package or the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact Prospectus, necessary in order to make the statements thereinin the Disclosure Package or the Prospectus as so amended or supplemented, in the light of the circumstances when the Disclosure Package or the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Disclosure Package or the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e)law.

Appears in 2 contracts

Samples: Underwriting Agreement (Handheld Entertainment, Inc.), Underwriting Agreement (Handheld Entertainment, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(bSections 4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Sections 4(d) and 4(f); provided, however that the only remedy the Agent shall have with respect to the failure by the Company to make such filing (other than the Agent’s rights under Section 3(b3(d) or Section 3(e)6 hereof) shall be to cease making sales under this Agreement until such amendment or supplement is filed. Notwithstanding the foregoing, the Company shall not be required to file such amendment or supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement.

Appears in 2 contracts

Samples: Open Market Sale (AC Immune SA), Open Market Sale (AC Immune SA)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at If any time event shall occur or condition exist during the period when a prospectus relating to the Offered Securities Shares is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act, Act or any event shall occur or condition exist similar rule) as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 2 contracts

Samples: Underwriting Agreement (Heron Therapeutics, Inc. /De/), Underwriting Agreement (Ap Pharma Inc /De/)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b4(d) and Section 3(c4(f) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the RepresentativeAgent’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(d) and Section 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; provided, however, that if the Company subsequently chooses to deliver an Issuance Notice to the Agent, the Company agrees to file such amendment or supplement prior to the delivery of such Issuance Notice.

Appears in 2 contracts

Samples: Open Market Sale (Sol-Gel Technologies Ltd.), Open Market Sale (Sol-Gel Technologies Ltd.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Company, counsel for the Company, Jefferies or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b) and Section 3(c) hereof)) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law, including the Securities Act or the rules thereunderAct. Neither the Representative’s Jxxxxxxxx’x consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 2 contracts

Samples: Dynavax Technologies Corp, Cerus Corp

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event shall occur or condition exist as a result of which it is necessary to amend the Registration Statement or amend or supplement the Prospectus in order to make the statements in the Prospectus, in light of the circumstances when the Prospectus is delivered to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters, it is otherwise necessary to amend the Registration Statement or supplement the Prospectus or to file a new registration statement to comply with the Securities Act, the Company agrees to promptly prepare (subject to Section 3(a)), file with the Commission, use its best efforts to have declared effective, if required, and furnish at its own expense to the Underwriters and to dealers, such amendments, supplements to the Prospectus or new registration statements so that the statements in the Prospectus does not as so amended or supplemented will not, in light of the circumstances when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus, as amended or supplemented, and the Registration Statement as amended, will comply with the Securities Act. If at any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement (or any other registration statement relating to the Notes) or the Prospectus or any Preliminary Prospectus or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaserprevailing at that subsequent time, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunder, the Company agrees (subject to Section 3(b) will promptly notify the Representatives and Section 3(c) hereof) to will promptly prepare, file with the Commission and furnishamend or supplement, at its own expense, such Issuer Free Writing Prospectus to the Underwriters and to any dealer upon requesteliminate or correct such conflict, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e)omission.

Appears in 2 contracts

Samples: Underwriting Agreement (JMP Group Inc.), Underwriting Agreement (JMP Group Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunder, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e).

Appears in 2 contracts

Samples: Underwriting Agreement (ARYA Sciences Acquisition Corp II), Underwriting Agreement (ARYA Sciences Acquisition Corp II)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(bSections 4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus (including by filing a document incorporated by reference therein) so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 4(d) and 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement.

Appears in 2 contracts

Samples: Open Market Sale Agreement (Spruce Biosciences, Inc.), Vaxcyte, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e).

Appears in 2 contracts

Samples: Underwriting Agreement (TKB Critical Technologies 1), Underwriting Agreement (TKB Critical Technologies 1)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist at any time during the Prospectus Delivery Period as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b) and Section 3(c) hereof)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestdealers, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law, including the Securities Act or the rules thereunderAct. Neither the Representative’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or and Section 3(e3(c).

Appears in 2 contracts

Samples: Underwriting Agreement (Celldex Therapeutics, Inc.), Underwriting Agreement (Celldex Therapeutics, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event or development shall occur or condition exist as a result of which it is necessary to amend the Disclosure Package or supplement the Prospectus so that the Prospectus does not as then supplemented would include an any untrue statement of a material fact or omit to state a any material fact necessary in order to make the statements therein in the light of the circumstances under which they were made not misleading, or if it is necessary to amend or supplement the Disclosure Package or the Prospectus, or to file under the Exchange Act any document incorporated by reference in the Disclosure Package or the Prospectus, in order to make the statements therein, in the light of the circumstances when the Disclosure Package or the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of any of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus Disclosure Package or the Prospectus, or to file under the Exchange Act any document incorporated by reference in the Disclosure Package or the Prospectus, to comply with the Securities Act applicable law or rules thereunderregulations, the Company agrees to (i) notify the Representatives of any such event or condition and (ii) promptly prepare (subject to Section 3(bSections 3(A)(a) and Section 3(c3(A)(e) hereof) to promptly prepare), file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestdealers, amendments or supplements to the Prospectus so that Disclosure Package or the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact Prospectus, necessary in order to make the statements thereinin the Disclosure Package or the Prospectus as so amended or supplemented, in the light of the circumstances when the Disclosure Package or the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Disclosure Package or the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e)law.

Appears in 2 contracts

Samples: Underwriting Agreement (Nuvasive Inc), Underwriting Agreement (Nuvasive Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating prior to the Offered Securities is required to be delivered under later of (x) the Securities ActClosing Date and (y) the end of the Prospectus Delivery Period (as defined below), any event shall occur or condition exist as a result of which it is necessary (i) the Time of Sale Information (prior to amend the Closing Date) or supplement the Prospectus so that (prior to the later of the Closing Date and the end of the Prospectus does not Delivery Period), in both cases as then amended or supplemented, would include an any untrue statement of a material fact or omit to state a any material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchasercircumstances, not misleading, misleading or if (ii) it shall be is necessary to amend the Registration Statement or supplement the Time of Sale Information (prior to the Closing Date) or the Prospectus (prior to the later of the Closing Date and the end of the Prospectus Delivery Period) to comply with the Securities Act or rules thereunderlaw, the Company agrees (and the Guarantors will promptly notify the Underwriters thereof and forthwith prepare and, subject to Section 3(bparagraph (a) and Section 3(c) hereof) to promptly prepareabove, file with the Commission (to the extent required) and furnish, at its own expense, furnish to the Underwriters and to any dealer upon requestsuch dealers as the Representatives may designate, such amendments or supplements to the Time of Sale Information (prior to the Closing Date) or the Prospectus (prior to the later of the Closing Date and the end of the Prospectus Delivery Period) as may be necessary so that the statements in the Time of Sale Information (prior to the Closing Date) or the Prospectus (prior to the later of the Closing Date and the end of the Prospectus Delivery Period), in both cases as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements thereinnot, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchasercircumstances, not be misleading or so that the Prospectus, as amended Time of Sale Information (prior to the Closing Date) or supplemented, the Prospectus (prior to the later of the Closing Date and the end of the Prospectus Delivery Period) will comply with law. The Company and the Securities Act or Guarantors hereby expressly acknowledge that the rules thereunder. Neither the Representative’s consent toindemnification and contribution provisions of Sections 8 and 9 hereof are specifically applicable and relate to each registration statement, nor delivery ofprospectus, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under referred to in this Section 3(b) or Section 3(e)3.

Appears in 2 contracts

Samples: Republic Services, Inc., Environtech Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Underwriters or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Underwriters’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 2 contracts

Samples: Underwriting Agreement (Enterprise Financial Services Corp), Underwriting Agreement (Great Southern Bancorp, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus (including by filing a document incorporated by reference therein) so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(d) and Section 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; however, the Company agrees not to provide an Issuance Notice or otherwise sell under this Agreement until such amendment or supplement is filed.

Appears in 2 contracts

Samples: Epizyme, Inc., Inozyme Pharma, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. (i) If the preliminary prospectus included in the Disclosure Package is being used to solicit offers to buy the Common Shares and any event or development shall occur or condition exist as a result of which it is necessary to amend or supplement the Disclosure Package in order to make the statements therein, in the light of the circumstances under which they were made or then prevailing, as the case may be, not misleading (in which case the Company agrees to notify the Underwriter of any such event or condition), or if in the reasonable opinion of the Underwriter it is otherwise necessary to amend or supplement the Disclosure Package to comply with law, the Company agrees to promptly prepare (subject to Section 3(a) hereof), file with the Commission and furnish to the Underwriter and to dealers, at its own expense, amendments or supplements to the Disclosure Package so that the statements in the Disclosure Package as so amended or supplemented will not be, in the light of the circumstances under which they were made or then prevailing, as the case may be, misleading or so that the Disclosure Package, as amended or supplemented, will comply with law. (ii) If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that Registration Statement or the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when under which they were made or then prevailing, as the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchasercase may be, not misleading, or if in the opinion of the Underwriter or counsel for the Underwriter it shall be is otherwise necessary to amend or supplement the Registration Statement or supplement the Prospectus to comply with applicable law, including in connection with the Securities Act or rules thereunderdelivery of the Prospectus, the Company agrees to promptly prepare (subject to Section 3(b) and Section 3(c3(a) hereof) to promptly prepare), file with the Commission and furnish, furnish at its own expense, expense to the Underwriters Underwriter and to any dealer upon requestdealers, amendments or supplements to the Registration Statement or the Prospectus so that the statements in the Registration Statement or the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements thereinnot, in the light of the circumstances when under which they were made or then prevailing, as the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchasercase may be, not misleading or so that the Registration Statement or the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e)law.

Appears in 2 contracts

Samples: Underwriting Agreement (Wireless Ronin Technologies Inc), Underwriting Agreement (Wireless Ronin Technologies Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus (including by filing a document incorporated by reference therein) so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 4(d) and 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; however, the Company agrees not to provide an Issuance Notice or otherwise sell under this Agreement until such amendment or supplement is filed.

Appears in 2 contracts

Samples: Open Market Sale (Cue Biopharma, Inc.), Cue Biopharma, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist at any time during the Prospectus Delivery Period as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b) and Section 3(c) hereof)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestdealers, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law, including the Securities Act or the rules thereunderAct. Neither the Representative’s Representatives’ consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or and Section 3(e3(c).

Appears in 2 contracts

Samples: Underwriting Agreement (Celldex Therapeutics, Inc.), Underwriting Agreement (Celldex Therapeutics, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Company, counsel for the Company, the Representatives or counsel for the Underwriters, it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b) and Section 3(c) hereof)) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section Sections 3(b) or Section 3(e(c).

Appears in 2 contracts

Samples: Underwriting Agreement (Neurocrine Biosciences Inc), Underwriting Agreement (Neurocrine Biosciences Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunder, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 2 contracts

Samples: Underwriting Agreement (Arya Sciences Acquisition Corp.), Underwriting Agreement (Arya Sciences Acquisition Corp.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist at any time during the Prospectus Delivery Period as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 2 contracts

Samples: Underwriting Agreement (Synta Pharmaceuticals Corp), Underwriting Agreement (Synta Pharmaceuticals Corp)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e).

Appears in 2 contracts

Samples: Underwriting Agreement (Healthwell Acquisition Corp. I), Underwriting Agreement (Healthwell Acquisition Corp. I)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b4(b) and Section 3(c4(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(b) or Section 3(e4(c).

Appears in 2 contracts

Samples: Underwriting Agreement (First Citizens Bancshares Inc /De/), Underwriting Agreement (First Busey Corp /Nv/)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e).

Appears in 2 contracts

Samples: Underwriting Agreement (Bright Lights Acquisition Corp.), Underwriting Agreement (Bright Lights Acquisition Corp.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b) and Section 3(c) hereof)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestdealers, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s or the Issuers’ obligations under Section Sections 3(b) or Section 3(e(c).

Appears in 2 contracts

Samples: Underwriting Agreement (Sabra Health Care REIT, Inc.), Underwriting Agreement (Sabra Health Care REIT, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus Prospectus, as then amended or supplemented, does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b5(c) and Section 3(c) hereof5(d)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters Agent and to any dealer upon requestdealers, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or (provided that the rules thereunderonly remedy the Agent shall have with respect to the failure by the Company to make any such filing, other than as set forth in Section 11 hereof, shall be to cease making sales of Shares pursuant to this Agreement). Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 5(c) or 5(d). In addition, the Company agrees to file on or before their respective due dates all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section 3(e13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for the duration of the Delivery Period. For the duration of the Delivery Period, the Company agrees (i) to include in its quarterly reports on Form 10-Q, and its annual reports on 10-K, a summary detailing, for the relevant reporting period, (1) the number of Shares sold through the Agent pursuant to this Agreement, (2) the net proceeds received by the Company from such sales and (3) the compensation paid by the Company to the Agent with respect to such sales or alternatively, (ii) to prepare a prospectus supplement or in such other filing permitted by the Securities Act or Exchange Act (each an “Interim Prospectus Supplement”) with such summary information and, at least once a quarter and subject this Section 5, file such Interim Prospectus Supplement pursuant to Rule 424(b) under the Securities Act (and within the time periods required by Rule 424(b) and Rules 430A, 430B or 430C under the Securities Act)).

Appears in 2 contracts

Samples: Sales Agency Agreement (Chicago Bridge & Iron Co N V), Sales Agency Agreement (Chicago Bridge & Iron Co N V)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c). “Prospectus Delivery Period” means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Shares by any Underwriter or dealer.

Appears in 2 contracts

Samples: Underwriting Agreement (AdaptHealth Corp.), Underwriting Agreement (AdaptHealth Corp.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(bSections 4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission (including by filing a document incorporated by reference therein) and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 4(d) and 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement.

Appears in 2 contracts

Samples: Open Market Sale Agreement (Adicet Bio, Inc.), Fate Therapeutics Inc

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event or development shall occur or condition exist as a result of which it is necessary to amend the Disclosure Package or supplement the Prospectus so that the Prospectus does not as then supplemented would include an any untrue statement of a material fact or omit to state a any material fact necessary in order to make the statements therein in the light of the circumstances under which they were made not misleading, or if it shall be necessary to amend or supplement the Disclosure Package or the Prospectus, or to file under the Exchange Act any document incorporated by reference in the Disclosure Package or the Prospectus, in order to make the statements therein, in the light of the circumstances when the Disclosure Package or the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus Disclosure Package or the Prospectus, or to file under the Exchange Act any document incorporated by reference in the Disclosure Package or the Prospectus, in order to comply with the Securities Act or rules thereunderlaw, the Company agrees to (i) notify the Representative of any such event or condition and (ii) promptly prepare (subject to Section 3(b3(a) and Section 3(c3(e) hereof) to promptly prepare), file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestdealers, amendments or supplements to the Prospectus so that Disclosure Package or the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact Prospectus, necessary in order to make the statements thereinin the Disclosure Package or the Prospectus as so amended or supplemented, in the light of the circumstances when the Disclosure Package or the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Disclosure Package or the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e)law.

Appears in 2 contracts

Samples: Underwriting Agreement (St Jude Medical Inc), Underwriting Agreement (St Jude Medical Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 4(d) and 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; however, the Company agrees not to provide an Issuance Notice or otherwise sell under this Agreement until such amendment or supplement is filed.

Appears in 2 contracts

Samples: Open Market Sale (Yumanity Therapeutics, Inc.), Yumanity Therapeutics, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Underwriter or counsel for the Underwriter it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters Underwriter and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the RepresentativeUnderwriter’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 2 contracts

Samples: Underwriting Agreement (Level One Bancorp Inc), Underwriting Agreement (Heartland Financial Usa Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus (including by filing a document incorporated by reference therein) so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(d) and Section 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no outstanding Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; however, the Company agrees not to provide an Issuance Notice or otherwise sell under this Agreement until such amendment or supplement is filed.

Appears in 2 contracts

Samples: Open Market Sale (Catabasis Pharmaceuticals Inc), Astria Therapeutics, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(d) and Section 4(f); provided, however, that the only remedy the Agent shall have with respect to the failure by the Company to make such filing (other than the Agent’s rights under Section 3(d) or Section 3(e)6 hereof) shall be to cease making sales under this Agreement until such amendment or supplement is filed; provided further, that the failure of the Company to file such amendment or supplement request shall not relieve the Company of any obligation or liability under Section 3(d) or Section 6 hereof, or affect the Agent’s right to rely on the representations and warranties made by the Company in this Agreement. Notwithstanding the foregoing, the Company shall not be required to file such amendment or supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement.

Appears in 2 contracts

Samples: 4D Molecular Therapeutics Inc., 374Water Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at If any time event shall occur or condition exist during the period when a prospectus relating to the Offered Securities Shares is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act, Act or any event shall occur or condition exist similar rule) as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 2 contracts

Samples: Underwriting Agreement (La Jolla Pharmaceutical Co), Underwriting Agreement (La Jolla Pharmaceutical Co)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(d) and Section 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; provided, however, the Company agrees not to provide an Issuance Notice or otherwise sell under this Agreement until such amendment or supplement is filed or it is determined that such amendment or supplement is no longer required.

Appears in 2 contracts

Samples: Tango Therapeutics, Inc., Kala Pharmaceuticals, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if if, in the opinion of counsel for each of the Underwriters and the Company, it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e).

Appears in 2 contracts

Samples: Underwriting Agreement (LF Capital Acquisition Corp. II), Underwriting Agreement (LF Capital Acquisition Corp. II)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus Prospectus, as then amended or supplemented, does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b5(b) and Section 3(c) hereof5(c)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters Agent and to any dealer upon requestdealers, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or (provided that the rules thereunderonly remedy the Agent shall have with respect to the failure by the Company to make any such filing, other than as set forth in Section 9 hereof, shall be to cease making sales of Shares pursuant to this Agreement). Neither the RepresentativeAgent’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 5(b) or 5(c). In addition, the Company agrees to file on or before their respective due dates all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section 3(e13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for the duration of the Delivery Period. For the duration of the Delivery Period, the Company agrees (i) to include in its quarterly reports on Form 10-Q, and its annual reports on Form10-K, a summary detailing, for the relevant reporting period, (1) the number of Shares sold through the Agent pursuant to this Agreement, (2) the net proceeds received by the Company from such sales and (3) the compensation paid by the Company to the Agent with respect to such sales or alternatively, (ii) to prepare a prospectus supplement or such other filing permitted by the Securities Act or Exchange Act (each an “Interim Prospectus Supplement”) with such summary information and, at least once a quarter and subject this Section 5, file such Interim Prospectus Supplement pursuant to Rule 424(b) under the Securities Act (and within the time periods required by Rule 424(b) and Rules 430A, 430B or 430C under the Securities Act)).

Appears in 1 contract

Samples: Sales Agency Agreement (Discovery Laboratories Inc /De/)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event or development shall occur or condition exist as a result of which it is necessary to amend the Disclosure Package or supplement the Prospectus so that the Prospectus does not as then supplemented would include an any untrue statement of a material fact or omit to state a any material fact necessary in order to make the statements therein in the light of the circumstances under which they were made not misleading, or if it shall be necessary to amend or supplement the Disclosure Package or the Prospectus in order to make the statements therein, in the light of the circumstances when the Disclosure Package or the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Disclosure Package or the Prospectus in order to comply with the Securities Act or rules thereunderlaw, the Company agrees to (i) notify the Representative of any such event or condition and (ii) promptly prepare (subject to Section 3(bSections 3(a) and Section 3(c3(e) hereof) to promptly prepare), file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestdealers, amendments or supplements to the Prospectus so that Disclosure Package or the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact Prospectus, necessary in order to make the statements thereinin the Disclosure Package or the Prospectus as so amended or supplemented, in the light of the circumstances when the Disclosure Package or the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Disclosure Package or the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e)law.

Appears in 1 contract

Samples: Underwriting Agreement (Minrad International, Inc.)

AutoNDA by SimpleDocs

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at During any time period when the delivery of a prospectus relating to the Offered Securities Shares is required (including in circumstances where such requirement may be satisfied pursuant to Rule 172) to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 4(d) and 4(f). Notwithstanding the foregoing, in the alternative the Company may suspend or Section 3(e)terminate the Issuance Notice upon written notice to the Agent and delay the filing of any amendment or supplement, if in the judgment of the Company, it is in the best interest of the Company.

Appears in 1 contract

Samples: Open Market Sale Agreement (Constellation Pharmaceuticals Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfIf any event shall occur or condition exist, at any time during the period when a prospectus relating to the Offered Securities Shares is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities ActAct or any similar rule), any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of Jefferies or counsel for the Underwriters, it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Xxxxxxxxx’x consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 1 contract

Samples: Underwriting Agreement (Arrowhead Pharmaceuticals, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(d) and Section 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; provided, however, that if the Company subsequently chooses to deliver an Issuance Notice to the Agent, the Company agrees to file such amendment or supplement prior to the delivery of such Issuance Notice.

Appears in 1 contract

Samples: Elys Game Technology, Corp.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus (including a document incorporated by reference in the Prospectus) so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(d) and Section 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; however, the Company agrees not to provide an Issuance Notice or otherwise sell under this Agreement until such amendment or supplement is filed or it is determined that such amendment or supplement is no longer required.

Appears in 1 contract

Samples: Dyne Therapeutics, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e).the

Appears in 1 contract

Samples: Underwriting Agreement (scPharmaceuticals Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(bSections 4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Sections 4(d) and 4(f), provided, however that the only remedy the Agent shall have with respect to the failure by the Company to make such filing (other than the Agent’s rights under Section 3(b3(d) or Section 3(e)6 hereof) shall be to cease making sales under this Agreement until such amendment or supplement is filed; provided further, that the failure of the Company to file such amendment or supplement request shall not relieve the Company of any obligation or liability under Section 3(d) or Section 6 hereof, or affect the Agent’s right to rely on the representations and warranties made by the Company in this Agreement. Notwithstanding the foregoing, the Company shall not be required to file such amendment or supplement if there is no pending Issuance Notice and the Company believes that it is in its best interests not to file such amendment or supplement.

Appears in 1 contract

Samples: Carisma Therapeutics Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsels for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c). The information contained in such amendment or supplement shall be made available, to the extent the Representatives reasonably determine that it is required by applicable French laws after consultation with the Company, to the public in France either through the Note d’Opération or, after the French Listing Prospectus has been approved by the AMF, through a press release broadcasted pursuant to applicable AMF rules or, if necessary, a supplement to the Note d’Opération.

Appears in 1 contract

Samples: Underwriting Agreement (Nanobiotix S.A.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(d) and Section 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; provided, however, that if the Company subsequently chooses to deliver an Issuance Notice to the Agent, the Company agrees to file such amendment or supplement prior to the delivery of such Issuance Notice.

Appears in 1 contract

Samples: Open Market Sale (MediWound Ltd.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event or development shall occur or condition exist as a result of which it is necessary to amend the Disclosure Package or supplement the Prospectus so that the Prospectus does not as then amended or supplemented would include an any untrue statement of a material fact or omit to state a any material fact necessary in order to make the statements therein in the light of the circumstances under which they were made or then prevailing, as the case may be, not misleading, or if it shall be necessary to amend or supplement the Disclosure Package or the Prospectus, or to file under the Exchange Act any document incorporated by reference in the Disclosure Package or the prospectus, in order to make the statements therein, in the light of the circumstances when the Disclosure Package or the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Underwriter or counsel for the Underwriter it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus Registration Statement, the Disclosure Package or the Prospectus, or to file a new registration statement containing the Prospectus, in order to comply with law, including in connection with the Securities Act or rules thereunderdelivery of the Prospectus, the Company agrees to promptly prepare (subject to Section 3(b) and Section 3(c3(a) hereof) to promptly prepare), file with the Commission (and furnish, use its best efforts to have any amendment to the Registration Statement or any new registration statement to be declared effective) and furnish at its own expense, expense to the Underwriters Underwriter and to any dealer upon requestdealers, amendments or supplements to the Prospectus Registration Statement, the Disclosure Package or the Prospectus, or any new registration statement, so that the statements in the Disclosure Package or the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements thereinnot, in the light of the circumstances when the Disclosure Package and the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Registration Statement, the Disclosure Package or the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunder. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e)law.

Appears in 1 contract

Samples: Underwriting Agreement (Essex Property Trust Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. No later than 10:00 a.m. Eastern Daylight Time on the business day immediately following the date of this Agreement, the Company shall file a Rule 462(b) Registration Statement with the Commission registering the offer and sale to the Underwriters in this offering of 600,000 Rule 462(b) Firm Shares and 90,000 Rule 462(b) Optional Shares. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that Registration Statement or the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when under which they were made or then prevailing, as the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchasercase may be, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend or supplement the Registration Statement or supplement the Prospectus to comply with applicable the Securities Act or rules thereunderthe Exchange Act, including in connection with the delivery of the Prospectus, the Company agrees to promptly prepare (subject to Section 3(b) and Section 3(c3(A)(a) hereof) to promptly prepare), file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestdealers, amendments or supplements to the Registration Statement or the Prospectus so that the statements in the Registration Statement or the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements thereinnot, in the light of the circumstances when under which they were made or then prevailing, as the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchasercase may be, not misleading or so that the Registration Statement or the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderlaw. Neither the Representative’s consent of the Representatives to, nor or delivery to the Representatives of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under this Section 3(b3(A)(c) or under Section 3(e)6.

Appears in 1 contract

Samples: Underwriting Agreement (Wireless Ronin Technologies Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or of counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 1 contract

Samples: Underwriting Agreement (ConnectOne Bancorp, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 4(d) and 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in the best interests not to file such amendment or supplement at such time; provided that no sales may be made and no Issuance Notice issued until such amendment or supplement has been filed.

Appears in 1 contract

Samples: VectivBio Holding AG

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b3(A)(b) and Section 3(c3(A)(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b3(A)(b) or Section 3(e3(A)(c). As used herein, the term “Prospectus Delivery Period” means such period of time after the first date of the public offering of the Offered ADSs as in the opinion of counsel for the Underwriters a prospectus relating to the Offered ADSs is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Offered ADSs by any Underwriter or dealer.

Appears in 1 contract

Samples: Underwriting Agreement (Avadel Pharmaceuticals PLC)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsels for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c). The information contained in such amendment or supplement shall be made available, to the extent required by applicable French laws, to the public in France, either through the Note d’Opération or, after the French Listing Prospectus has been approved by the AMF, through a press release broadcasted pursuant to applicable AMF rules or, if necessary, a supplement to the French Listing Prospectus.

Appears in 1 contract

Samples: Underwriting Agreement (Nanobiotix S.A.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 1 contract

Samples: Underwriting Agreement (Par Technology Corp)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Company, counsel for the Company, the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus (or any document to be filed with the Commission and incorporated by reference therein) so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplementedsupplemented (or any document to be filed with the Commission and incorporated by reference therein), will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 1 contract

Samples: Underwriting Agreement (Codiak BioSciences, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period (as defined below), at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b3(A)(b) and Section 3(c3(A)(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b3(A)(b) or Section 3(e3(A)(c). As used herein, the term “Prospectus Delivery Period” means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Shares by any Underwriter or dealer.

Appears in 1 contract

Samples: Underwriting Agreement (Medpace Holdings, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the reasonable opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c). As used herein, the term “Prospectus Delivery Period” means such period of time after the first date of the public offering of the Offered ADSs as in the opinion of counsel for the Underwriters a prospectus relating to the Offered ADSs is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Offered ADSs by any Underwriter or dealer.

Appears in 1 contract

Samples: Underwriting Agreement (ASLAN Pharmaceuticals LTD)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b3(d) and Section 3(c) hereof3(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 3(d) and 3(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Placement Notice, the Company believes that it is in its best interest not to file such amendment or supplement, and no such amendment is necessary to make the Prospectus, as used in connection with a sale pursuant to any prior Placement Notice, not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances existing at the time the Prospectus was delivered to a purchaser, not misleading and to be in compliance with applicable law, including the Securities Act.

Appears in 1 contract

Samples: Sales Agreement (Esperion Therapeutics, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Company, counsel for the Company, the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b3(c) and Section 3(c) hereof3(d)) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b3(c) or Section 3(e3(d).

Appears in 1 contract

Samples: Underwriting Agreement (Morphic Holding, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b3(c) and Section 3(c3(d)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b3(c) or Section 3(e3(d).

Appears in 1 contract

Samples: Underwriting Agreement (Ocular Therapeutix, Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(bSections 4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Sections 4(d) and 4(f); provided, however that the only remedy the Agent shall have with respect to the failure by the Company to make such filing (other than the Agent’s rights under Section 3(b3(d) or Section 3(e)6 hereof) shall be to cease making sales under this Agreement until such amendment or supplement is filed; provided, further, that the failure of the Company to file such amendment or supplement request shall not relieve the Company of any obligation or liability under Section 3(d) or Section 6 hereof, or affect the Agent’s right to rely on the representations and warranties made by the Company in this Agreement. Notwithstanding the foregoing, the Company shall not be required to file such amendment or supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement.

Appears in 1 contract

Samples: Freeline Therapeutics Holdings PLC

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to during the Offered Securities is required to be delivered under the Securities ActProspectus Delivery Period, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 1 contract

Samples: Underwriting Agreement (Marinus Pharmaceuticals Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the reasonable opinion of the Agents or counsel for the Agents it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b5(d) and Section 3(c) hereof5(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgents, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the Representative’s Agents’ consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 5(d) and 5(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interests not to file such amendment or supplement. Prior to the initial sale of any Shares, the Company shall file a final ATM Prospectus pursuant to Rule 424(b) relating to the Shares.

Appears in 1 contract

Samples: AFC Gamma, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the reasonable opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c). As used herein, the term “Prospectus Delivery Period” means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is required by law to be delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) in connection with sales of the Shares by any Underwriter or dealer.

Appears in 1 contract

Samples: Underwriting Agreement (Theseus Pharmaceuticals, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not not, when delivered to a prospective purchaser (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule), include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaserin which they were made, not misleading, or if in the opinion of the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable Law, the Company agrees (subject to Section 3(b) and Section 3(c) hereof)) to promptly prepare, file with the Commission and the Canadian Securities Regulators and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not not, when delivered to a prospective purchaser (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule), include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaserin which they were made, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable Law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 1 contract

Samples: Underwriting Agreement (Planet 13 Holdings Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at During any time period when the delivery of a prospectus relating to the Offered Securities Shares is required (including in circumstances where such requirement may be satisfied pursuant to Rule 172) to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 4(d) and 4(f). Notwithstanding the foregoing, in the alternative the Company can suspend or Section 3(e)terminate the Issuance Notice upon written notice to the Agent and delay the filing of any amendment or supplement, if in the judgment of the Company, it is in the best interest of the Company.

Appears in 1 contract

Samples: Open Market Sale (Translate Bio, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfIf any event shall occur or condition exist, at any time during the period when a prospectus relating to the Offered Securities Shares is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities ActAct or any similar rule), any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Representatives’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 1 contract

Samples: Underwriting Agreement (Arrowhead Research Corp)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b4 (d) and Section 3(c4 (e) hereof) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the RepresentativeAgent’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4 (d) and Section 4 (e) hereof. Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; provided, however, that if the Company subsequently chooses to deliver an Issuance Notice to the Agent, the Company agrees to file such amendment or supplement prior to the delivery of such Issuance Notice.

Appears in 1 contract

Samples: Open Market Sale (Corbus Pharmaceuticals Holdings, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(bSections 4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus (including by filing a document incorporated by reference therein) so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 4(d) and 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; however, the Company agrees not to provide an Issuance Notice or otherwise sell under this Agreement until such amendment or supplement is filed or it is determined that such amendment or supplement is no longer required.

Appears in 1 contract

Samples: Humacyte, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar ​ ​ rule) to a purchaser, not misleading, or if in the opinion of the Underwriters or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Underwriters’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 1 contract

Samples: Underwriting Agreement (Bridgewater Bancshares Inc)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating The Company will comply with the Securities Act and the Exchange Act so as to permit the completion of the distribution of the Offered Securities is required to be delivered under as contemplated in this Agreement and the Securities Act, Prospectus. If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b) and Section 3(c) hereof)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestdealers, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the Representative’s Representatives’ consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section Sections 3(b) or Section 3(e(c). If necessary and appropriate, the Company shall file a registration statement pursuant to, and in accordance with, Rule 462(b) under the Securities Act and pay the applicable fees in accordance with the Securities Act.

Appears in 1 contract

Samples: Underwriting Agreement (BCD Semiconductor Manufacturing LTD)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b4(d) and Section 3(c4(e) hereof) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the RepresentativeAgent’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b4(d) and Section 4(e) hereof. Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; provided, however, that if the Company subsequently chooses to deliver an Issuance Notice to the Agent, the Company agrees to file such amendment or supplement prior to the delivery of such Issuance Notice.

Appears in 1 contract

Samples: Corbus Pharmaceuticals Holdings, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary in the opinion of counsel for the Company or for the Underwriters to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b3 (b) and Section 3(c3 (c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3 (c).

Appears in 1 contract

Samples: Underwriting Agreement (Icahn Enterprises L.P.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities ActAct or any similar rule), any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the reasonable opinion of the Representative or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply in all material respects with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b) and Section 3(c) hereof) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestdealers, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law, including the Securities Act or the rules thereunderAct. Neither the Representative’s consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section Sections 3(b) or Section 3(e3(c).

Appears in 1 contract

Samples: Underwriting Agreement (Chefs' Warehouse, Inc.)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. IfDuring the Prospectus Delivery Period, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, if any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the Underwriters it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with the Securities Act or rules thereunderapplicable law, the Company agrees (subject to Section 3(b) and Section 3(c)) hereof) hereof to promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with the Securities Act or the rules thereunderapplicable law. Neither the Representative’s Underwriters’ consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b) or Section 3(e3(c).

Appears in 1 contract

Samples: Underwriting Agreement (Hanmi Financial Corp)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent, the Forward Seller or the Forward Purchaser or counsel for the Agent, the Forward Seller or the Forward Purchaser it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters Agent, the Forward Seller and to any dealer upon requestthe Forward Purchaser, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s, the Forward Seller’s or the Forward Purchaser’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 4(d) and 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement.

Appears in 1 contract

Samples: Open Market Sale (Opthea LTD)

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b‎Section 4(d) and Section 3(c) hereof‎Section 4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(b‎Section 4(d) and ‎Section 4(f); provided, however that the only remedy the Agent shall have with respect to the failure by the Company to make such filing (other than the Agent’s rights under ‎Section 3(d) or Section 3(e)6 hereof) shall be to cease making sales under this Agreement until such amendment or supplement is filed; provided further, that the failure of the Company to file such amendment or supplement request shall not relieve the Company of any obligation or liability under ‎Section 3(d) or Section 6 hereof, or affect the Agent’s right to rely on the representations and warranties made by the Company in this Agreement. Notwithstanding the foregoing, the Company shall not be required to file such amendment or supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement.

Appears in 1 contract

Samples: CytomX Therapeutics, Inc.

Amendments and Supplements to the Prospectus and Other Securities Act Matters. If, at any time when a prospectus relating to the Offered Securities is required to be delivered under the Securities Act, If any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it shall be is otherwise necessary to amend the Registration Statement or supplement the Prospectus to comply with applicable law, including the Securities Act or rules thereunderAct, the Company agrees (subject to Section 3(b4(d) and Section 3(c) hereof4(f)) to promptly prepare, file with the Commission and furnish, furnish at its own expense, expense to the Underwriters and to any dealer upon requestAgent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act or the rules thereunderAct. Neither the RepresentativeAgent’s consent to, nor or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company’s obligations under Section 3(bSections 4(d) and 4(f). Notwithstanding the foregoing, the Company shall not be required to file such amendment or Section 3(e)supplement if there is no pending Issuance Notice and the Company believes that it is in its best interest not to file such amendment or supplement; provided, however, the Company agrees not to provide an Issuance Notice or otherwise sell under this Agreement until such amendment or supplement is filed or it is determined that such amendment or supplement is no longer required.

Appears in 1 contract

Samples: Prime Medicine, Inc.

Time is Money Join Law Insider Premium to draft better contracts faster.